LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC THERAPIES: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 2 STUDY

被引：0

作者：

Mease, Philip J. ^{[1
]}

Setty, Arathi ^{[2
]}

Papp, Kim ^{[3
]}

Van den Bosch, Filip ^{[4
]}

Tsuji, Shigeyoshi ^{[5
]}

Keiserman, Mauro ^{[6
]}

Bu, Xianwei ^{[2
]}

Chen, Liang ^{[2
]}

Mccaskill, Reva ^{[2
]}

Mcdearmon-Blondell, Erin ^{[2
]}

Wung, Peter ^{[2
]}

Tillett, William ^{[7
]}

机构：

[1] Providence St Joseph Hlth, Rheumatol, Swedish Med Ctr, Seattle, WA USA

[2] AbbVie Inc, Immunol, N Chicago, IL USA

[3] Papp Clin Res & Prob Med Res, Dermatol, Waterloo, ON, Canada

[4] Ghent Uni, VIB Ctr Inflammat Res, Internal Med & Pediat, Ghent, Belgium

[5] Natl Hosp Org, Osaka Minami Med Ctr, Orthopaed Rheumatol, Osaka, Japan

[6] Pontif Catholic Univ, Sch Med, Rheumatol, Porto Alegre, RS, Brazil

[7] Royal Natl Hosp Rheumat Dis, Rheumatol, Bath, Avon, England

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P185

引用

页数：1